These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20815042)

  • 1. Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer.
    Laurent C; Svrcek M; Flejou JF; Chenard MP; Duclos B; Freund JN; Reimund JM
    Inflamm Bowel Dis; 2011 Jan; 17(1):232-40. PubMed ID: 20815042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer.
    Serafino A; Moroni N; Zonfrillo M; Andreola F; Mercuri L; Nicotera G; Nunziata J; Ricci R; Antinori A; Rasi G; Pierimarchi P
    Oncotarget; 2014 Feb; 5(4):978-92. PubMed ID: 24657851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.
    Khare V; Dammann K; Asboth M; Krnjic A; Jambrich M; Gasche C
    Inflamm Bowel Dis; 2015 Feb; 21(2):287-96. PubMed ID: 25569743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR4, IgA and EpCAM Expression in Colorectal Cancer and Their Possible Association with Microbiota as a Pathogenic Factor; An Immunohistochemical and Genetic Study.
    Hafez FS; Shakweer MM; Sabry D; Tawfik AM; El-Beah SM; Elsheshtawy NM; Shash LS; Salama DEA; Gaballah A
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):627-636. PubMed ID: 38415550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis.
    Walsh S; Murphy M; Silverman M; Odze R; Antonioli D; Goldman H; Loda M
    Am J Pathol; 1999 Nov; 155(5):1511-8. PubMed ID: 10550307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Mitochondria Dysfunction in Inflammatory Bowel Diseases and Colorectal Cancer.
    Kłos P; Dabravolski SA
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors.
    Nagayama S; Yamada E; Kohno Y; Aoyama T; Fukukawa C; Kubo H; Watanabe G; Katagiri T; Nakamura Y; Sakai Y; Toguchida J
    Cancer Sci; 2009 Mar; 100(3):405-12. PubMed ID: 19134005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of single-cell transcriptome reveals heterogeneity and commonality in the immune microenvironment of colorectal cancer and inflammatory bowel disease.
    Lv H; Mu Y; Zhang C; Zhao M; Jiang P; Xiao S; Sun H; Wu N; Sun D; Jin Y
    Front Immunol; 2024; 15():1356075. PubMed ID: 38529274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent nuclear β-catenin expression in pulmonary enteric-type adenocarcinoma according to the current World Health Organization criteria.
    Kishikawa S; Hayashi T; Takamochi K; Ura A; Sasahara N; Saito T; Suzuki K; Yao T;
    Virchows Arch; 2023 Nov; 483(5):699-703. PubMed ID: 37740071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A polymorphic enhancer near GREM1 influences bowel cancer risk through differential CDX2 and TCF7L2 binding.
    Lewis A; Freeman-Mills L; de la Calle-Mustienes E; Giráldez-Pérez RM; Davis H; Jaeger E; Becker M; Hubner NC; Nguyen LN; Zeron-Medina J; Bond G; Stunnenberg HG; Carvajal JJ; Gomez-Skarmeta JL; Leedham S; Tomlinson I
    Cell Rep; 2014 Aug; 8(4):983-90. PubMed ID: 25131200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms.
    Frigerio S; Lartey DA; D'Haens GR; Grootjans J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of caspases-4 and -5 during inflammatory bowel disease and colorectal cancer: Diagnostic and therapeutic potential.
    Flood B; Oficjalska K; Laukens D; Fay J; O'Grady A; Caiazza F; Heetun Z; Mills KH; Sheahan K; Ryan EJ; Doherty GA; Kay E; Creagh EM
    Clin Exp Immunol; 2015 Jul; 181(1):39-50. PubMed ID: 25943872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic potential of CDX2 in colorectal cancer: Harmonizing biology and clinical practice.
    Badia-Ramentol J; Gimeno-Valiente F; Duréndez E; Martínez-Ciarpaglini C; Linares J; Iglesias M; Cervantes A; Calon A; Tarazona N
    Cancer Treat Rev; 2023 Dec; 121():102643. PubMed ID: 37871463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fat diet plus HNF1A variant promotes polyps by activating β-catenin in early-onset colorectal cancer.
    Song H; Sontz RA; Vance MJ; Morris JM; Sheriff S; Zhu S; Duan S; Zeng J; Koeppe E; Pandey R; Thorne CA; Stoffel EM; Merchant JL
    JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37219942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemopreventive Effects of Strawberry and Black Raspberry on Colorectal Cancer in Inflammatory Bowel Disease.
    Chen T; Shi N; Afzali A
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31163684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive Oxygen Species and Ferroptosis at the Nexus of Inflammation and Colon Cancer.
    Huang W; Aabed N; Shah YM
    Antioxid Redox Signal; 2023 Sep; 39(7-9):551-568. PubMed ID: 36792928
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of glycolysis in inflammatory bowel disease and its associated colorectal cancer.
    Xia Y; Zhang L; Ocansey DKW; Tu Q; Mao F; Sheng X
    Front Endocrinol (Lausanne); 2023; 14():1242991. PubMed ID: 37881499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel disease, colorectal cancer and type 2 diabetes mellitus: The links.
    Jurjus A; Eid A; Al Kattar S; Zeenny MN; Gerges-Geagea A; Haydar H; Hilal A; Oueidat D; Matar M; Tawilah J; Hussein IH; Schembri-Wismayer P; Cappello F; Tomasello G; Leone A; Jurjus RA
    BBA Clin; 2016 Jun; 5():16-24. PubMed ID: 27051585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of a novel cell line and xenotransplant mouse model derived from feline colorectal adenocarcinoma.
    Uneyama M; Chambers JK; Fujii T; Nakashima K; Uchida K
    Vet Pathol; 2024 Mar; 61(2):190-200. PubMed ID: 37515543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulators of G-Protein Signaling (RGS) in Sporadic and Colitis-Associated Colorectal Cancer.
    Swierczynski M; Kasprzak Z; Makaro A; Salaga M
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.